Skip to main content

Published locations for Ibrutinib/rituximab effective, safe as frontline treatment for older patients with MCL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ibrutinib/rituximab effective, safe as frontline treatment for older patients with MCL

User login

  • Reset your password
  • /content/ibrutinib/rituximab-effective-safe-frontline-treatment-older-patients-mcl
  • /fedprac/article/206270/mantle-cell-lymphoma/ibrutinib/rituximab-effective-safe-frontline-treatment
  • /hematologynews/article/206270/mantle-cell-lymphoma/ibrutinib/rituximab-effective-safe-frontline
  • /oncologypractice/article/206270/mantle-cell-lymphoma/ibrutinib/rituximab-effective-safe-frontline
  • /hematology-oncology/article/206270/mantle-cell-lymphoma/ibrutinib/rituximab-effective-safe-frontline
  • /hematologytimes/article/206270/mantle-cell-lymphoma/ibrutinib/rituximab-effective-safe-frontline
  • /b-cell-lymphoma-icymi/article/206270/mantle-cell-lymphoma/ibrutinib/rituximab-effective-safe